Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis.

ABSTRACT:

Background

The postpartum period provides an opportunity for birthing people with opioid use disorder (OUD) to consider their future reproductive health goals. However, the relationship between the use of medication for opioid use disorder (MOUD) and contraception utilization is not well understood. We used multistate administrative claims data to compare contraception utilization rates among postpartum people with OUD initiating buprenorphine (BUP) versus no medication (psychosocial services receipt without MOUD (PSY)) in the United States (US).

Methods

In this retrospective cohort study, we analyzed data from the Merative™ MarketScan^® Multi-State Medicaid Databases 2016-2021 among postpartum women with OUD who did and did not initiate BUP during pregnancy. Our p

SUBMITTER: Xu KY 

PROVIDER: S-EPMC11702041 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature